2.50 USD
↘ 0.09 (3.29%)LIVE (AS OF 03:14 PM EDT)
Niagen Bioscience, Inc. Common Stock
NAGENASDAQ • USD
Market: OPEN
Shares of Niagen Bioscience, Inc. Common Stock (NAGE) are trading at $2.50. Both sides of the analysis point lower: technicals flash "Strong Sell" and fundamentals confirm with a "Sell" reading. Notable factors include a robust Altman Z-Score, a weak Piotroski F-Score of 0/9, a bearish Death Cross on the long-term moving averages and bearish long-term moving average alignment. The stock looks compelling on valuation, with multiples below sector averages across P/E, P/B, and EV/EBITDA.
Technical & fundamental data as of Oct 15, 2026.
Open?$2.58
High?$2.59
Low?$2.47
Prev. Close?$2.58
Volume?422.1K
Avg. Volume?494.8K
VWAP?$2.52
Rel. Volume?0.85x
Bid / Ask
Bid?$2.49 × 900
Ask?$2.50 × 2.5K
Spread?$0.01
Midpoint?$2.50
Valuation & Ratios
Market Cap?204.1M
Shares Out?79.6M
Float?51.9M
Float %?65.1%
P/E Ratio?12.77
P/B Ratio?2.47
EPS?$0.20
Dividend?0.00%
Ex-Dividend?N/A
News
Profile
Niagen Bioscience Inc is the leader in NAD+ (nicotinamide adenine dinucleotide) science and healthy-aging research. It is dedicated to advancing healthspan through precision science and innovative NAD+-boosting solutions. It is is clinically proven to increase NAD+ levels efficiently and effectively, and is the key ingredient powering our suite of Niagen brands.
Employees
117
Market Cap
204.1M
Industry
MEDICINAL CHEMICALS & BOTANICAL PRODUCTS
Website
Listed
2008-06-24
Address
10900 WILSHIRE BLVD
LOS ANGELES, CA 90024
Phone: 310-388-6706
LOS ANGELES, CA 90024
Phone: 310-388-6706
Technical OutlookStrong Sell
Strong SellNeutralStrong Buy
Long-Term (Tide)?▼ Bearish(-3/3)
Medium-Term (Wave)?▼ Bearish(-2/3)
Short-Term (Ripple)?– Neutral(0/3)
MA Alignment?Bearish Alignment
Full Technical Analysis →Fundamental OutlookSell
Strong SellNeutralStrong Buy
F-Score?3
Z-Score?99
Momentum?10
Short Sent.?34
Piotroski F-Score?0/9Weak
Altman Z-Score?5.50Safe
Confidence?40%Low
Short InterestHigh
Short % of Float?7.47%Elevated
Short Interest?3.9M
Days to Cover?9.9
Free Float51.9M
Avg Daily Volume393.0K
Settlement Date2026-09-30
Financial Health
Current Ratio?6.50Strong
Quick Ratio?5.13Strong
Cash Ratio?4.43Strong
Debt/Equity?0.00Low
ValuationATTRACTIVELY VALUEDvs 1 peers + S&P 500
Score89/100
P/E?12.8CHEAP▾
Peers100
S&P89
P/B?2.47CHEAP▾
Peers100
S&P65
P/S?1.58CHEAP▾
Peers100
S&P77
P/FCF?36.0PRICEY▾
Peers100
S&P20
EV/EBITDA?11.9CHEAP▾
Peers100
S&P69
EV/Sales?1.06CHEAP▾
Peers100
S&P91
Returns & Efficiency
ROE?19.4%STRONG▾
Peers50
S&P65
ROA?15.0%STRONG▾
Peers50
S&P87
Cash Flow & Enterprise
FCF?$5.7M
Enterprise Value?$137.4M
Fundamentals ratios updated end of day